Mick J M van Eijs Lotte E van der Wagen Rogier Mous Roos J Leguit Lisette van de Corput Anne S R van Lindert Britt B M Suelmann Anna M Kamphuis Stefan Nierkens Karijn P M Suijkerbuijk
10.1007/s00262-022-03230-4
Cancer Immunol Immunother
2023 Jan;72(1):249-255.
case series immune checkpoint inhibitor leukemia myeloid neoplasms second primary cancer
CC BY
https://pubmed.ncbi.nlm.nih.gov/35691988/
Hematologic Neoplasms / drug therapy Leukemia, Myelogenous, Chronic, BCR-ABL Positive Leukemia, Myeloid, Acute Myelodysplastic Syndromes / drug therapy Myelodysplastic Syndromes / genetics
Hematologic Neoplasms / drug therapy Leukemia, Myelogenous, Chronic, BCR-ABL Positive Leukemia, Myeloid, Acute Myelodysplastic Syndromes / drug therapy Myelodysplastic Syndromes / genetics Humans Immune Checkpoint Inhibitors / therapeutic use Immune Checkpoint Inhibitors
PMC9188911
35691988
Hematologic malignancies following immune checkpoint inhibition for solid tumors
2023